NCT06609512

A Clinical Study of Enlicitide and the Effect of Food in Healthy Adult Participants (MK-0616-033)

A Clinical Study to Evaluate the Effect of Fasting Duration on the Pharmacokinetics of the Enlicitide in Healthy Adult Participants

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 20 (actual)
• Sponsor: Merck Sharp & Dohme LLC · Industry
• Sex: All
• Age: 18 Years – 55 Years
• Healthy volunteers: Accepted

Summary

The goal of the study is to learn what happens to enlicitide decanoate in a healthy person's body over time when taken on an empty stomach or with food. Researchers will compare what happens to enlicitide in a healthy person's body over time when enlicitide is taken with or without food. Enlicitide decanoate will be referred to as "enlicitide" throughout.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	Enlicitide	Oral Tablet

Timeline

• Start date: 2024-10-21
• Primary completion: 2025-01-13
• Completion: 2025-01-31
• First posted: 2024-09-24
• Last updated: 2025-02-07

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study